September 29 marks World Heart Day. The focus for 2012 is on women, children and heart disease. Cardiovascular disease (CVD) causes one in three female deaths and 1 million babies are born annually worldwide with a congenital heart defect. Putting the spotlight on these vulnerable populations is more crucial than ever. In order to raise …
Read More
Some fascinating new research just reported in the Journal of the American College of Cardiology has shown that atrial fibrillation treatment success more than doubles when patients with medication-resistant high blood pressure [hypertension] and atrial fibrillation have a pulmonary vein isolation catheter ablation augmented by a kidney-related procedure called “renal artery denervation.” To learn more …
Read More
In September of 2012, there will be two Congressional briefings on atrial fibrillation for National Atrial Fibrillation Awareness Month. The featured speakers on September 18 will be Hugh Calkins, MD, FHRS, a world-renowned expert on atrial fibrillation and Heart Rhythm Society (HRS) Incoming President, and Mellanie True Hills, an afib patient and CEO and Founder …
Read More
The American College of Cardiology recently interviewed our founder and CEO, Mellanie True Hills, about how she came to start Atrial Fibrillation Awareness Month and what has happened as a result. Access the video at: American College of Cardiology Interviews StopAfib.org Founder About Having Created Atrial Fibrillation Awareness Month
Read More
StopAfib.org interviews Dr. Randall Wolf of the Indiana Heart Hospital
Read More
In this video, creator of the mini maze surgical procedure, Dr. Randall Wolf, describes the evolution of the procedure and how it came to be called the Wolf mini maze. He also discusses the effect of a minimalist approach to lesions, as well as how the mini maze procedure compares to catheter ablation. Watch the …
Read More
Over 10,000 patients, caregivers, healthcare professionals, policy makers and the general public from 136 countries have signed the world’s only Global Atrial Fibrillation Patient Charter calling for government action to help prevent millions of people from dying or becoming disabled by a stroke caused by Atrial Fibrillation (AF). To learn more, see: Global Support Increases …
Read More
StopAfib interviews Dr. James Reiffel Find a transcript and more on Dr. Reiffel at: www.stopafib.org In this video interview at Heart Rhythm 2012, Dr. James Reiffel updates us on new directions in drug treatments for atrial fibrillation. He talks about the combination of ranolazine (Ranexa) and dronedarone (Multaq), both used …
Read More
At Heart Rhythm 2012, Dr. James Reiffel gave us an update on new medications for treating atrial fibrillation, including the combination of low doses of ranolazine (Ranexa) and dronedarone (Multaq). He also talked about rate control vs. rhythm control for afib, and how the decision can vary by age and level of symptoms. Watch the …
Read More
The Atrial Fibrillation Optimal Treatment Task Force, led by the Alliance for Aging Research, has just released a consensus statement developed by a group of leading afib stroke prevention experts. We at StopAfib.org are proud to have been part of the development of this consensus statement, which recommends a process for assessing afib stroke and …
Read More